Prelude Capital Management’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-109,330
| Closed | -$883K | – | 1347 |
|
|
2025
Q1 | $883K | Buy |
+109,330
| New | +$883K | 0.07% | 284 |
|
|
2024
Q3 | – | Sell |
-135,200
| Closed | -$675K | – | 1479 |
|
|
2024
Q2 | $675K | Sell |
135,200
-9,100
| -6% | -$45.4K | 0.05% | 363 |
|
|
2024
Q1 | $890K | Buy |
+144,300
| New | +$890K | 0.05% | 386 |
|
|
2021
Q4 | – | Sell |
-13,893
| Closed | -$68K | – | 1963 |
|
|
2021
Q3 | $68K | Buy |
+13,893
| New | +$68K | ﹤0.01% | 1177 |
|
|
2021
Q1 | – | Sell |
-27,294
| Closed | -$215K | – | 1424 |
|
|
2020
Q4 | $215K | Buy |
+27,294
| New | +$215K | 0.01% | 643 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1904 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1745 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1625 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1809 |
|